Learn About Our Doctoral Students' Interests, Research, and More. Last Names A–M.

Dr. Liu is a population health researcher interested to study and address leading causes of child mortality. She has multidisciplinary background in medicine ...

My research interests include measuring and monitoring coverage of maternal, newborn, and child health (MNCH) interventions, mortality, and causes of death, assessing socio-economic inequalities in ...

The Johns Hopkins Center for Global Women's Health and Gender Equity is pleased to announce the second cohort of the Gender Equity/GBV Evidence Accelerator Fellowship Program for 2025–2026. This ...

Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y, Sawadogo-Lewis T, Walker N. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in ...

This open Q&A session is all about supporting whatever’s going on for you right now. We’ll troubleshoot everything from navigating your next move to finding hidden job opportunities, networking ...

My research aims to improve maternal, child, and neonatal health in low-resource settings. Most of my research focuses on (1) large-scale effectiveness evaluations of maternal, neonatal, and child ...

This week's MMI Thursday Seminar Breastfeeding, gut microbiota and infant health features Fengyi Wan, PhD. Dr. Wan is a Professor in the Departments of Biochemistry and Molecular Biology and Molecular ...

The Johns Hopkins Bloomberg School of Public Health has again been recognized as the top public health school in the nation by its peer schools and programs, as reported by U.S. News & World Report.

As of November 2024, over 70 million Americans were enrolled in Medicaid, the government health insurance program that offers free or low-cost health care to adults and families with limited income, ...

Add to Calendar 15 jhu-bsph-322261 Vaccine Day 2025 - Control of Hib Disease: From Navajo and White Mountain Apache Communities to Global Impact Vaccine Day showcases the breadth of vaccine-related ...

In 1971, the FDA approved the measles-mumps-rubella (MMR) vaccine, which combined three vaccines that had been approved previously—in 1963, 1967, and 1969, respectively. The vaccine has proven safe ...